Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-15 Purchase | 2024-10-16 4:18 pm | Ceribell Inc. | CBLL | Tammenoms Bakker Juliet Director | 237,234 | $17 | $4,032,978 | 2,481,728 (Indirect Direct) | View |
| 2024-05-17 Purchase | 2024-05-21 4:11 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 5,000 | $61.09 | $305,457 | 36,388 (Indirect Direct) | View |
| 2024-02-12 Purchase | 2024-02-15 4:15 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 8,000 | $50.83 | $406,673 | 31,388 (Indirect Direct) | View |
| 2023-11-28 Sale | 2023-11-30 7:32 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 494,313 | $29.73 | $14,695,695 | 471,098 (Indirect Direct) | View |
| 2023-11-14 Sale | 2023-11-16 7:31 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 500,000 | $27.18 | $13,590,750 | 960,791 (Indirect Direct) | View |
| 2023-11-07 Purchase | 2023-11-09 8:32 pm | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) | View |
| 2023-09-07 Sale | 2023-09-11 6:15 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 32,950 | $30.14 | $992,969 | 1,460,791 (Indirect Direct) | View |
| 2023-08-25 Sale | 2023-08-28 7:44 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 16,208 | $29.25 | $474,129 | 1,317,027 (Indirect Direct) | View |
| 2023-08-17 Sale | 2023-08-18 4:08 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 33,135 | $29.62 | $981,570 | 1,775,863 (Indirect Direct) | View |
| 2023-02-10 Purchase | 2023-02-13 6:20 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 480,000 | $12.5 | $6,000,000 | 2,997,321 (Indirect Direct) | View |
| 2023-02-06 Purchase | 2023-02-08 7:40 pm | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) | View |
| 2022-04-19 Purchase | 2022-04-21 6:04 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,355,000 | $3.69 | $4,999,950 | 4,174,379 (Indirect) | View |
| 2022-02-10 Purchase | 2022-04-05 07:24 am | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) | View |
| 2022-02-02 Purchase | 2022-02-02 9:25 pm | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 175,000 | $27 | $4,725,000 | 2,139,771 (Indirect) | View |
| 2021-08-03 Purchase | 2021-08-05 7:41 pm | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 637,500 | $16 | $10,200,000 | 562,838 (Indirect Direct) | View |
| 2021-07-19 Purchase | 2021-07-20 9:39 pm | RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Longitude Prime Partners LLC Longitude Prime Fund L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 150,000 | $20 | $3,000,000 | 779,032 (Indirect) | View |
| 2021-05-18 Purchase | 2021-05-18 8:20 pm | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) | View |
| 2021-05-11 Purchase | 2021-05-11 8:29 pm | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 235,000 | $17 | $3,995,000 | 3,220,775 (Indirect) | View |
| 2020-10-20 Purchase | 2020-10-22 7:53 pm | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 233,333 | $18 | $4,199,994 | 3,918,691 (Indirect) | View |
| 2020-09-18 Sale | 2020-09-22 6:01 pm | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 9,167 | $42.67 | $391,119 | 1,959,859 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-15 Conversion | 2024-10-16 4:18 pm | N/A N/A | Ceribell Inc. | CBLL | Tammenoms Bakker Juliet Director | 2,140,600 | $0 | 2,481,728 (Indirect) | View |
| 2024-10-11 Option Award | 2024-10-16 4:18 pm | N/A N/A | Ceribell Inc. | CBLL | Tammenoms Bakker Juliet Director | 6,618 | $0 | 2,481,728 (Direct) | View |
Ownership | 2024-10-10 4:17 pm | N/A N/A | Ceribell Inc. | CBLL | Tammenoms Bakker Juliet Director | 0 | $0 | 2,237,876 (Indirect) | View |
| 2024-06-06 Option Award | 2024-06-10 4:07 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 2,554 | $0 | 38,942 (Direct) | View |
| 2023-11-30 Other | 2023-11-30 7:32 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 447,710 | $0 | 471,098 (Indirect) | View |
| 2023-11-07 Conversion | 2023-11-09 8:32 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 24,018,702 | $0 | 2,567,100 (Indirect) | View |
Ownership | 2023-11-02 9:36 pm | N/A N/A | Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 0 | $0 | 2,067,743 (Indirect) | View |
| 2023-08-24 Other | 2023-08-28 7:44 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 268,686 | $0 | 1,317,027 (Indirect) | View |
| 2023-08-09 Other | 2023-08-11 4:13 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 530,100 | $0 | 2,339,098 (Indirect) | View |
| 2023-06-14 Other | 2023-06-16 4:49 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 268,761 | $0 | 1,829,259 (Indirect) | View |
| 2023-06-01 Option Award | 2023-06-05 4:36 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 5,731 | $0 | 2,539,037 (Direct) | View |
| 2023-05-26 Other | 2023-05-31 6:09 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 530,285 | $0 | 3,063,591 (Indirect) | View |
| 2022-06-02 Option Award | 2022-06-03 8:24 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 10,349 | $0 | 2,517,321 (Direct) | View |
| 2022-04-27 Other | 2022-04-29 7:07 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 2,155,801 | $0 | 2,163,816 (Indirect) | View |
| 2022-01-25 Exercise | 2022-01-27 9:23 pm | 2020-01-22 2022-04-10 | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,964,576 | $13.2 | 1,964,771 (Indirect) | View |
| 2021-08-03 Conversion | 2021-08-05 7:41 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 3,727,226 | $0 | 562,838 (Indirect) | View |
| 2021-08-03 Tax Withholding | 2021-08-05 7:41 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 28,125 | $0 | 562,838 (Indirect) | View |
| 2021-08-03 Exercise | 2021-08-05 7:41 pm | 2017-02-24 N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 72,604 | $0 | 562,838 (Indirect) | View |
| 2021-07-30 Option Award | 2021-08-02 8:17 pm | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 5,859 | $0 | 5,859 (Direct) | View |
Ownership | 2021-07-29 10:42 am | N/A N/A | RxSight Inc. | RXST | Tammenoms Bakker Juliet Director | 0 | $0 | 1,891,738 (Indirect) | View |
| 2021-07-19 Conversion | 2021-07-20 9:39 pm | N/A N/A | RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Longitude Prime Partners LLC Longitude Prime Fund L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 23,838,431 | $0 | 779,032 (Indirect) | View |
Ownership | 2021-07-14 7:35 pm | N/A N/A | RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 6,558,675 (Indirect) | View |
| 2021-05-17 Other | 2021-05-19 4:58 pm | N/A N/A | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 1,005,012 | $0 | 1,015,036 (Indirect) | View |
| 2021-05-18 Conversion | 2021-05-18 8:20 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 2,187,504 | $0 | 3,096,594 (Indirect) | View |
Ownership | 2021-05-13 7:27 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 2,187,504 (Indirect) | View |
| 2021-05-11 Conversion | 2021-05-11 8:29 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 5,971,550 | $0 | 3,220,775 (Indirect) | View |
Ownership | 2021-05-06 9:25 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 0 | $0 | 2,985,775 (Indirect) | View |
| 2021-04-14 Other | 2021-04-15 9:04 pm | N/A N/A | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 1,005,012 | $0 | 1,010,024 (Indirect) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 855,944 | $0 | 856,835 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-22 7:53 pm | N/A N/A | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 3,685,358 | $0 | 3,918,691 (Indirect) | View |
| 2020-10-15 Option Award | 2020-10-19 6:07 pm | N/A 2030-10-14 | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 6,666 | $0 | 6,666 (Direct) | View |
Ownership | 2020-10-15 8:18 pm | N/A N/A | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 0 | $0 | 3,685,358 (Indirect) | View |